172 related articles for article (PubMed ID: 32249134)
21. A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms.
Werneck MA; Kortas GT; de Andrade AG; Castaldelli-Maia JM
CNS Drugs; 2018 Dec; 32(12):1113-1129. PubMed ID: 30361897
[TBL] [Abstract][Full Text] [Related]
22. Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations.
Fischer B; Russell C; Sabioni P; van den Brink W; Le Foll B; Hall W; Rehm J; Room R
Am J Public Health; 2017 Aug; 107(8):e1-e12. PubMed ID: 28644037
[TBL] [Abstract][Full Text] [Related]
23. Telephone interventions for symptom management in adults with cancer.
Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
[TBL] [Abstract][Full Text] [Related]
24. Patient Counseling Guidelines for the Use of Cannabis for the Treatment of Chemotherapy-Induced Nausea/Vomiting and Chronic Pain.
Makary P; Parmar JR; Mims N; Khanfar NM; Freeman RA
J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):216-225. PubMed ID: 31070496
[TBL] [Abstract][Full Text] [Related]
25. Psychosocial interventions for cannabis use disorder.
Gates PJ; Sabioni P; Copeland J; Le Foll B; Gowing L
Cochrane Database Syst Rev; 2016 May; 2016(5):CD005336. PubMed ID: 27149547
[TBL] [Abstract][Full Text] [Related]
26. Routes of administration, reasons for use, and approved indications of medical cannabis in oncology: a scoping review.
Vinette B; Côté J; El-Akhras A; Mrad H; Chicoine G; Bilodeau K
BMC Cancer; 2022 Mar; 22(1):319. PubMed ID: 35331185
[TBL] [Abstract][Full Text] [Related]
27. Cannabis use among adults undergoing cancer treatment.
Azizoddin DR; Cohn AM; Ulahannan SV; Henson CE; Alexander AC; Moore KN; Holman LL; Boozary LK; Sifat MS; Kendzor DE
Cancer; 2023 Nov; 129(21):3498-3508. PubMed ID: 37354093
[TBL] [Abstract][Full Text] [Related]
28. Medicinal Cannabis and Implications for Workplace Health and Safety: Scoping Review of Systematic Reviews.
O'Neill V; Karanikas N; Sav A; Murphy P
Workplace Health Saf; 2023 Sep; 71(9):400-410. PubMed ID: 37077169
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Aviram J; Samuelly-Leichtag G
Pain Physician; 2017 Sep; 20(6):E755-E796. PubMed ID: 28934780
[TBL] [Abstract][Full Text] [Related]
30. Cannabis use and acute coronary syndrome.
Richards JR; Bing ML; Moulin AK; Elder JW; Rominski RT; Summers PJ; Laurin EG
Clin Toxicol (Phila); 2019 Oct; 57(10):831-841. PubMed ID: 30964363
[No Abstract] [Full Text] [Related]
31. Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Medical Cannabis and Cannabis-based Medicines for Chronic Noncancer Pain: A Systematic Review.
Mohiuddin MM; Mizubuti GB; Haroutounian S; Smith SM; Rice ASC; Campbell F; Park R; Gilron I
Clin J Pain; 2020 Apr; 36(4):302-319. PubMed ID: 31977375
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials.
Deshpande A; Mailis-Gagnon A; Zoheiry N; Lakha SF
Can Fam Physician; 2015 Aug; 61(8):e372-81. PubMed ID: 26505059
[TBL] [Abstract][Full Text] [Related]
33. Should Oncologists Recommend Cannabis?
Abrams DI
Curr Treat Options Oncol; 2019 Jun; 20(7):59. PubMed ID: 31161270
[TBL] [Abstract][Full Text] [Related]
34. Use of cannabinoids in cancer patients: A Society of Gynecologic Oncology (SGO) clinical practice statement.
Whitcomb B; Lutman C; Pearl M; Medlin E; Prendergast E; Robison K; Burke W
Gynecol Oncol; 2020 May; 157(2):307-311. PubMed ID: 31932107
[No Abstract] [Full Text] [Related]
35. Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).
Mersiades AJ; Tognela A; Haber PS; Stockler M; Lintzeris N; Simes J; McGregor I; Olver I; Allsop DJ; Gedye C; Kirby AC; Morton RL; Fox P; Clarke S; Briscoe K; Aghmesheh M; Wong N; Walsh A; Hahn C; Grimison P
BMJ Open; 2018 Sep; 8(9):e020745. PubMed ID: 30209152
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Rice J; Cameron M
Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
[TBL] [Abstract][Full Text] [Related]
37. The Potential Proconvulsant Effects of Cannabis: a Scoping Review.
Kaczor EE; Greene K; Zacharia J; Tormoehlen L; Neavyn M; Carreiro S
J Med Toxicol; 2022 Jul; 18(3):223-234. PubMed ID: 35352276
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
